胰岛素自身免疫综合征:一例氯吡格雷诱发的自身免疫性低血糖
报告一例67岁男性胰岛素自身免疫综合征(IAS)病例:因缺血性心脏病启用含氯吡格雷的双联抗血小板治疗9个月后出现严重高胰岛素性低血糖,需持续静脉输注10%葡萄糖维持血糖正常。检查示胰岛素、胰岛素原、C肽及抗胰岛素抗体滴度升高,携带HLA-DRB1*04单倍型,多项定位检查排除胰岛素瘤。停用氯吡格雷、口服地塞米松及二氮嗪均未能安全撤除葡萄糖输注,最终血浆置换有效。
要点
- 氯吡格雷的活性代谢物含巯基,可能诱发胰岛素自身免疫综合征(IAS)。
- 本例表现为严重高胰岛素性低血糖,胰岛素、胰岛素原、C肽及抗胰岛素抗体滴度升高。
- 停用氯吡格雷、地塞米松及二氮嗪未能安全撤除葡萄糖输注,血浆置换最终有效。
核心结论
- 氯吡格雷使用广泛,胰岛素自身免疫综合征应被记为一种罕见的不良反应。
研究设计与样本
- 个案报告:一例67岁男性患者,因缺血性心脏病启用含氯吡格雷的双联抗血小板治疗9个月后出现低血糖。
主要发现
- 患者因严重高胰岛素性低血糖入院,需持续静脉输注10%葡萄糖以维持血糖正常。
- 低血糖与胰岛素、胰岛素原、C肽及抗胰岛素抗体滴度升高以及HLA-DRB1*04单倍型相关,多项定位检查未发现胰岛素瘤,诊断为胰岛素自身免疫综合征。
- 停用氯吡格雷、口服地塞米松及二氮嗪治疗不足以安全撤除葡萄糖输注,血浆置换最终有效。
关键数值与推荐
- 患者需持续静脉输注10%葡萄糖以维持血糖正常。
- 低血糖伴胰岛素、胰岛素原、C肽及抗胰岛素抗体滴度升高,并携带HLA-DRB1*04单倍型。
- 多项定位检查未发现胰岛素瘤。
- 停用氯吡格雷、口服地塞米松及二氮嗪未能安全撤除葡萄糖输注,血浆置换最终有效。
临床怎么用
- 作者认为,鉴于氯吡格雷使用广泛,应将该药相关的胰岛素自身免疫综合征记为其罕见不良反应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Insulin autoimmune syndrome (IAS) is characterized by hyperinsulinemic hypoglycemia with elevated anti-insulin antibodies. Most commonly observed in the Japanese population, elsewhere it is rare and associated with autoimmune diseases, plasma cell dyscrasias, or sulfhydryl group medications. The active metabolite of clopidogrel has a sulfhydryl group and here we report a case of clopidogrel-induced IAS. CASE DESCRIPTION: A 67-year-old man was admitted with severe hyperinsulinemic hypoglycemia requiring continuous intravenous infusion of 10% dextrose to sustain euglycemia. His symptoms of hypoglycemia had started after commencing dual antiplatelet therapy (including clopidogrel) for ischemic heart disease 9 months earlier. The hypoglycemia was associated with elevated insulin, proinsulin, c-peptide, and anti-insulin antibody titers as well as the HLA-DRB1*04 haplotype. Multiple localizing studies were negative for an insulinoma. A diagnosis of IAS was thus made. Clopidogrel cessation, oral dexamethasone, and diazoxide therapy were not sufficient to safely wean the dextrose infusion. Plasma exchange was ultimately effective. CONCLUSIONS: This case highlights a case of severe IAS. Given the ubiquity of clopidogrel, IAS should be remembered as a rare adverse effect.
引用
- Calder GL, Ward GM, Sachithanandan N, et al. Insulin Autoimmune Syndrome: A Case of Clopidogrel-induced Autoimmune Hypoglycemia. J Clin Endocrinol Metab. 2020. PMID: 32182368. doi:10.1210/clinem/dgz301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。